19.10.2015 Views

Global Alopecia Clinical Trials Review Market Size, Share & Forecast to 2015 Radiant Insights, Inc

Summary GlobalData's clinical trial report, "Alopecia Global Clinical Trials Review, H1, 2015" provides an overview of Alopecia clinical trials scenario. This report provides top line data relating to the clinical trials on Alopecia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. Read Complete Report with TOC @ http://www.radiantinsights.com/research/alopecia-global-clinical-trials-review-h1-2015 The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level

Summary

GlobalData's clinical trial report, "Alopecia Global Clinical Trials Review, H1, 2015" provides an overview of Alopecia clinical trials scenario. This report provides top line data relating to the clinical trials on Alopecia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Read Complete Report with TOC @ http://www.radiantinsights.com/research/alopecia-global-clinical-trials-review-h1-2015

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Global</strong> <strong>Alopecia</strong> <strong>Clinical</strong> <strong>Trials</strong> <strong>Review</strong> <strong>Market</strong> <strong>Size</strong>, <strong>Share</strong> &<br />

<strong>Forecast</strong> <strong>to</strong> <strong>2015</strong>: <strong>Radiant</strong> <strong>Insights</strong>, <strong>Inc</strong><br />

Summary<br />

<strong>Global</strong>Data's clinical trial report, "<strong>Alopecia</strong> <strong>Global</strong> <strong>Clinical</strong> <strong>Trials</strong> <strong>Review</strong>, H1, <strong>2015</strong>" provides an<br />

overview of <strong>Alopecia</strong> clinical trials scenario. This report provides <strong>to</strong>p line data relating <strong>to</strong> the clinical<br />

trials on <strong>Alopecia</strong>. Report includes an overview of trial numbers and their average enrollment in <strong>to</strong>p<br />

countries conducted across the globe. The report offers coverage of disease clinical trials by region,<br />

country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent<br />

drugs for in-progress trials (based on number of ongoing trials). <strong>Global</strong> Data <strong>Clinical</strong> Trial Reports are<br />

generated using <strong>Global</strong> Data's proprietary database - Pharma eTrack <strong>Clinical</strong> trials database. <strong>Clinical</strong><br />

trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the<br />

globe. <strong>Clinical</strong> trials database undergoes periodic update by dynamic process.<br />

Read Complete Report with TOC @ http://www.radiantinsights.com/research/alopecia-globalclinical-trials-review-h1-<strong>2015</strong><br />

The report enhances the decision making capabilities and helps <strong>to</strong> create an effective counter strategies <strong>to</strong><br />

gain competitive advantage.<br />

Scope<br />

- The report provides a snapshot of the global clinical trials landscape<br />

- Report provides <strong>to</strong>p level data related <strong>to</strong> the clinical trials by Region, Country (G7 & E7), Trial Status,<br />

Trial Phase, Sponsor Type and End point status<br />

- The report reviews <strong>to</strong>p companies involved and enlists all trials (Trial title, Phase, and Status) pertaining<br />

<strong>to</strong> the company<br />

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason<br />

for unaccomplishment<br />

- The Report provides enrollment trends for the past five years<br />

- Report provides latest news for the past three months<br />

Reasons <strong>to</strong> buy<br />

- Assists in formulating key business strategies with regards <strong>to</strong> investment<br />

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost


- Provides <strong>to</strong>p level analysis of <strong>Global</strong> <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong> which helps in identifying key business<br />

opportunities<br />

- Supports understanding of trials count and enrollment trends by country in global therapeutics market<br />

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed<br />

and uncompleted (terminated, suspended or withdrawn) trials<br />

- Facilitates clinical trial assessment of the indication on a global, regional and country level<br />

Table of Contents<br />

Table of Contents 2<br />

List of Tables 4<br />

List of Figures 5<br />

Introduction 6<br />

<strong>Alopecia</strong> 6<br />

Read Complete Report with TOC @ http://www.radiantinsights.com/research/alopecia-globalclinical-trials-review-h1-<strong>2015</strong><br />

Report Guidance 6<br />

<strong>Clinical</strong> <strong>Trials</strong> by Region 7<br />

<strong>Clinical</strong> <strong>Trials</strong> and Average Enrollment by Country 8<br />

Top Five Countries Contributing <strong>to</strong> <strong>Clinical</strong> <strong>Trials</strong> in Asia-Pacific 10<br />

Top Five Countries Contributing <strong>to</strong> <strong>Clinical</strong> <strong>Trials</strong> in Europe 11<br />

Top Countries Contributing <strong>to</strong> <strong>Clinical</strong> <strong>Trials</strong> in North America 12<br />

Top Countries Contributing <strong>to</strong> <strong>Clinical</strong> <strong>Trials</strong> in Middle East and Africa 13<br />

Top Countries Contributing <strong>to</strong> <strong>Clinical</strong> <strong>Trials</strong> in Central and South America 14<br />

<strong>Clinical</strong> <strong>Trials</strong> by G7 Countries: Proportion of <strong>Alopecia</strong> <strong>to</strong> Derma<strong>to</strong>logy <strong>Clinical</strong> <strong>Trials</strong> 15<br />

<strong>Clinical</strong> <strong>Trials</strong> by Phase in G7 Countries 16<br />

<strong>Clinical</strong> <strong>Trials</strong> in G7 Countries by Trial Status 17<br />

<strong>Clinical</strong> <strong>Trials</strong> by E7 Countries: Proportion of <strong>Alopecia</strong> <strong>to</strong> Derma<strong>to</strong>logy <strong>Clinical</strong> <strong>Trials</strong> 18


<strong>Clinical</strong> <strong>Trials</strong> by Phase in E7 Countries 19<br />

<strong>Clinical</strong> <strong>Trials</strong> in E7 Countries by Trial Status 20<br />

<strong>Clinical</strong> <strong>Trials</strong> by Phase 21<br />

In Progress <strong>Trials</strong> by Phase 22<br />

<strong>Clinical</strong> <strong>Trials</strong> by Trial Status 23<br />

<strong>Clinical</strong> <strong>Trials</strong> by End Point Status 24<br />

Unaccomplished <strong>Trials</strong> of <strong>Alopecia</strong> 25<br />

Subjects Recruited Over a Period of Time 27<br />

<strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type 28<br />

Prominent Sponsors 29<br />

Read Complete Report with TOC @ http://www.radiantinsights.com/research/alopecia-globalclinical-trials-review-h1-<strong>2015</strong><br />

Top Companies Participating in <strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> 30<br />

Prominent Drugs 31<br />

<strong>Clinical</strong> Trial Profiles 32<br />

<strong>Clinical</strong> Trial Overview of Top Companies 32<br />

Actavis plc 32<br />

<strong>Clinical</strong> Trial Overview of Actavis plc 32<br />

Johnson & Johnson 33<br />

<strong>Clinical</strong> Trial Overview of Johnson & Johnson 33<br />

GlaxoSmithKline Plc 34<br />

<strong>Clinical</strong> Trial Overview of GlaxoSmithKline Plc 34<br />

RepliCel Life Sciences, <strong>Inc</strong>. 35<br />

<strong>Clinical</strong> Trial Overview of RepliCel Life Sciences, <strong>Inc</strong>. 35<br />

Glenmark Pharmaceuticals Ltd. 36<br />

<strong>Clinical</strong> Trial Overview of Glenmark Pharmaceuticals Ltd. 36


Axis <strong>Clinical</strong> <strong>Trials</strong> 37<br />

<strong>Clinical</strong> Trial Overview of Axis <strong>Clinical</strong> <strong>Trials</strong> 37<br />

Kirin Holdings Company, Limited 38<br />

<strong>Clinical</strong> Trial Overview of Kirin Holdings Company, Limited 38<br />

Dr. Reddy's Labora<strong>to</strong>ries Limited 39<br />

<strong>Clinical</strong> Trial Overview of Dr. Reddy's Labora<strong>to</strong>ries Limited 39<br />

CRA Holdings, <strong>Inc</strong>. 40<br />

<strong>Clinical</strong> Trial Overview of CRA Holdings, <strong>Inc</strong>. 40<br />

Cosmo Pharmaceuticals S.p.A 41<br />

<strong>Clinical</strong> Trial Overview of Cosmo Pharmaceuticals S.p.A 41<br />

Read Complete Report with TOC @ http://www.radiantinsights.com/research/alopecia-globalclinical-trials-review-h1-<strong>2015</strong><br />

<strong>Clinical</strong> Trial Overview of Top Institutes / Government 42<br />

University of Minnesota 42<br />

<strong>Clinical</strong> Trial Overview of University of Minnesota 42<br />

Aderans Research Institute 43<br />

<strong>Clinical</strong> Trial Overview of Aderans Research Institute 43<br />

Columbia University 44<br />

<strong>Clinical</strong> Trial Overview of Columbia University 44<br />

Faculty of Medicine Siriraj Hospital, Mahidol University 45<br />

<strong>Clinical</strong> Trial Overview of Faculty of Medicine Siriraj Hospital, Mahidol University 45<br />

University of British Columbia 46<br />

<strong>Clinical</strong> Trial Overview of University of British Columbia 46<br />

Tehran University of Medical Sciences 47<br />

<strong>Clinical</strong> Trial Overview of Tehran University of Medical Sciences 47<br />

Ablon Skin Institute 48


<strong>Clinical</strong> Trial Overview of Ablon Skin Institute 48<br />

Charite - Universitatsmedizin Berlin 49<br />

<strong>Clinical</strong> Trial Overview of Charite - Universitatsmedizin Berlin 49<br />

Kurdistan University of Medical Sciences 50<br />

<strong>Clinical</strong> Trial Overview of Kurdistan University of Medical Sciences 50<br />

Mae Fah Luang University Hospital 51<br />

<strong>Clinical</strong> Trial Overview of Mae Fah Luang University Hospital 51<br />

Five Key <strong>Clinical</strong> Profiles 52<br />

Appendix 71<br />

Read Complete Report with TOC @ http://www.radiantinsights.com/research/alopecia-globalclinical-trials-review-h1-<strong>2015</strong><br />

Abbreviations 71<br />

Definitions 71<br />

Research Methodology 72<br />

Secondary Research 72<br />

About <strong>Global</strong>Data 73<br />

Contact Us 73<br />

Disclaimer 73<br />

Source 73<br />

List of Tables<br />

<strong>Alopecia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Region, <strong>2015</strong>* 7<br />

<strong>Alopecia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> and Average Enrollment by Top Countries, <strong>2015</strong>* 8<br />

<strong>Alopecia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Top Countries, <strong>2015</strong>* 9<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Asia-Pacific, Top Five Countries, <strong>2015</strong>* 10<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Europe, Top Five Countries, <strong>2015</strong>* 11


<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, North America, Top Countries, <strong>2015</strong>* 12<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Middle East and Africa, Top Countries, <strong>2015</strong>* 13<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Central and South America, Top Countries, <strong>2015</strong>* 14<br />

Proportion of <strong>Alopecia</strong> <strong>to</strong> Derma<strong>to</strong>logy <strong>Clinical</strong> <strong>Trials</strong>, G7 Countries (%), <strong>2015</strong>* 15<br />

<strong>Alopecia</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 16<br />

<strong>Alopecia</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 17<br />

Proportion of <strong>Alopecia</strong> <strong>to</strong> Derma<strong>to</strong>logy <strong>Clinical</strong> <strong>Trials</strong>, E7 Countries (%), <strong>2015</strong>* 18<br />

<strong>Alopecia</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 19<br />

<strong>Alopecia</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 20<br />

<strong>Alopecia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 21<br />

Read Complete Report with TOC @ http://www.radiantinsights.com/research/alopecia-globalclinical-trials-review-h1-<strong>2015</strong><br />

<strong>Alopecia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Phase <strong>2015</strong>* 22<br />

<strong>Alopecia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 23<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, by End Point Status, <strong>2015</strong>* 24<br />

<strong>Alopecia</strong> Therapeutics, <strong>Global</strong>, Withdrawn <strong>Clinical</strong> <strong>Trials</strong>, <strong>2015</strong>* 25<br />

<strong>Alopecia</strong> Therapeutics, <strong>Global</strong>, Terminated <strong>Clinical</strong> <strong>Trials</strong>, <strong>2015</strong>* 26<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Average Enrollment Target Trends, 2010-2014 27<br />

<strong>Alopecia</strong> Therapeutics <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type, <strong>2015</strong>* 28<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Key Sponsors, <strong>2015</strong>* 29<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Top Companies by Phase, <strong>2015</strong>* 30<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Ongoing <strong>Clinical</strong> <strong>Trials</strong> by Prominent Drugs, <strong>2015</strong>* 31<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Actavis plc, <strong>2015</strong>* 32<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Johnson & Johnson, <strong>2015</strong>* 33<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by GlaxoSmithKline Plc, <strong>2015</strong>* 34<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by RepliCel Life Sciences, <strong>Inc</strong>.,<br />

<strong>2015</strong>* 35


<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Glenmark Pharmaceuticals Ltd.,<br />

<strong>2015</strong>* 36<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Axis <strong>Clinical</strong> <strong>Trials</strong>, <strong>2015</strong>* 37<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Kirin Holdings Company,<br />

Limited, <strong>2015</strong>* 38<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Dr. Reddy's Labora<strong>to</strong>ries<br />

Limited, <strong>2015</strong>* 39<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by CRA Holdings, <strong>Inc</strong>., <strong>2015</strong>* 40<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Cosmo Pharmaceuticals S.p.A,<br />

<strong>2015</strong>* 41<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by University of Minnesota, <strong>2015</strong>*<br />

42<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Aderans Research Institute,<br />

<strong>2015</strong>* 43<br />

Read Complete Report with TOC @ http://www.radiantinsights.com/research/alopecia-globalclinical-trials-review-h1-<strong>2015</strong><br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Columbia University, <strong>2015</strong>* 44<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Faculty of Medicine Siriraj<br />

Hospital, Mahidol University, <strong>2015</strong>* 45<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by University of British Columbia,<br />

<strong>2015</strong>* 46<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Tehran University of Medical<br />

Sciences, <strong>2015</strong>* 47<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Ablon Skin Institute, <strong>2015</strong>* 48<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Charite - Universitatsmedizin<br />

Berlin, <strong>2015</strong>* 49<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Kurdistan University of Medical<br />

Sciences, <strong>2015</strong>* 50<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Mae Fah Luang University<br />

Hospital, <strong>2015</strong>* 51


List of Figures<br />

<strong>Alopecia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Region (%), <strong>2015</strong>* 7<br />

<strong>Alopecia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> and Average Enrollment by Top Countries, <strong>2015</strong>* 8<br />

<strong>Alopecia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Top Countries, <strong>2015</strong>* 9<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Asia-Pacific, Top Five Countries (%), <strong>2015</strong>* 10<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Europe, Top Five Countries (%), <strong>2015</strong>* 11<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, North America, Top Countries (%), <strong>2015</strong>* 12<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Middle East and Africa, Top Countries (%), <strong>2015</strong>* 13<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Central and South America, Top Countries (%), <strong>2015</strong>* 14<br />

Read Complete Report with TOC @ http://www.radiantinsights.com/research/alopecia-globalclinical-trials-review-h1-<strong>2015</strong><br />

Proportion of <strong>Alopecia</strong> <strong>to</strong> Derma<strong>to</strong>logy <strong>Clinical</strong> <strong>Trials</strong>, G7 Countries (%), <strong>2015</strong>* 15<br />

<strong>Alopecia</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 16<br />

<strong>Alopecia</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 17<br />

Proportion of <strong>Alopecia</strong> <strong>to</strong> Derma<strong>to</strong>logy <strong>Clinical</strong> <strong>Trials</strong>, E7 Countries (%), <strong>2015</strong>* 18<br />

<strong>Alopecia</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 19<br />

<strong>Alopecia</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 20<br />

<strong>Alopecia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Phase (%), <strong>2015</strong>* 21<br />

<strong>Alopecia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Phase, <strong>2015</strong>* 22<br />

<strong>Alopecia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 23<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, by End Point Status, <strong>2015</strong>* 24<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Average Enrollment Target Trends, 2010-2014 27<br />

<strong>Alopecia</strong> Therapeutics <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type (%), <strong>2015</strong>* 28<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Key Sponsors, <strong>2015</strong>* 29<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Top Companies by Phase, <strong>2015</strong>* 30<br />

<strong>Alopecia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Ongoing <strong>Clinical</strong> <strong>Trials</strong> by Prominent Drugs, <strong>2015</strong>* 31


<strong>Global</strong>Data Methodology 72<br />

Read Complete Report with TOC @ http://www.radiantinsights.com/research/alopecia-globalclinical-trials-review-h1-<strong>2015</strong><br />

About <strong>Radiant</strong> <strong>Insights</strong><br />

<strong>Radiant</strong> <strong>Insights</strong> is a platform for companies looking <strong>to</strong> meet their market research and business<br />

intelligence requirements. We assist and facilitate organizations and individuals procure market research<br />

reports, helping them in the decision making process. We have a comprehensive collection of reports,<br />

covering over 40 key industries and a host of micro markets. In addition <strong>to</strong> over extensive database of<br />

reports, our experienced research coordina<strong>to</strong>rs also offer a host of ancillary services such as, research<br />

partnerships/ tie-ups and cus<strong>to</strong>mized research solutions.<br />

For More Information, Visit <strong>Radiant</strong> <strong>Insights</strong><br />

Contact:<br />

Michelle Thoras<br />

Corporate Sales Specialist, USA<br />

<strong>Radiant</strong> <strong>Insights</strong>, <strong>Inc</strong><br />

Phone: 1-415-349-0054<br />

Toll Free: 1-888-202-9519<br />

Email: sales@radiantinsights.com<br />

Blog URL: http://www.radiantinsightsinc.blogspot.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!